Seaport Therapeutics, Inc. SPTX
Set alert
19.60 USD -1.50 -7.11%
At close · Oct 30
19.60 0.00 0.00%
After hours · Oct 30, 4:33 PM ET
19.00 Day range 21.16
15.25 52-week range 27.84
- YTD
- -1.21%
- 1 year
- -1.21%
- Open
- 20.96
- Prev close
- 21.10
- Mkt cap
- 1.05B
- Vol
- 549.19K
- Avg vol
- 203.02K
- EPS
- -5.81
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 19.00
- High
- 21.16
- Forward P/E
- -7.60
- Beta
- 0.00
- Short ratio
- 12.17
- Inst. own
- 70.99%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 2, 2026
- 50-d avg
- 21.25
- 200-d avg
- 20.13
- 1y target
- 37.00
Financial health
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
Valuation
P/E -10.2×
FY 2025 5y median -10.2× FY 2025
P/S 0.0×
FY 2025 5y median 0.0× FY 2025
P/B -8.3×
FY 2025 5y median -8.3× FY 2025
P/FCF -9.8×
FY 2025 5y median -9.8× FY 2025
EV/EBITDA -8.5×
FY 2025 5y median -8.5× FY 2025
EV/Sales 0.0×
FY 2025 5y median 0.0× FY 2025
FCF Yield -10.2%
FY 2025 5y median -10.2% FY 2025
Profitability
Gross Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2025 5y median 0.0% FY 2025
ROE 80.9%
FY 2025 5y median 80.9% FY 2025
ROIC -36.7%
FY 2025 5y median -36.7% FY 2025
ROA -30.1%
FY 2025 5y median -30.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2025 FY 2025
Operating Income 0.0%
FY 2025 FY 2025
EPS (diluted) 0.0%
FY 2025 FY 2025
Free Cash Flow 0.0%
FY 2025 FY 2025
Financial Health
Current Ratio 17.5×
FY 2025 5y median 17.5× FY 2025
Quick Ratio 17.5×
FY 2025 5y median 17.5× FY 2025
Debt / Equity -0.1×
FY 2025 5y median -0.1× FY 2025
Net Debt / EBITDA 0.5×
FY 2025 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2025 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2025 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2025 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31